Surgery Websites
Transplant Surgery »  Meet the Team »  Transplant Surgeons »  Seiji Yamaguchi, MD, FACS
Seiji Yamaguchi, MD, FACS

Seiji Yamaguchi, MD, FACS

  • Assistant Professor of Surgery
  • Division of Abdominal Transplant Surgery

Contact Information

505 Parnassus Avenue, #M893
San Francisco, CA 94117
Phone: 415-353-8725
Open Popup

Dr. Yamaguchi completed his medical degree at Georgetown University School of Medicine and his general surgery residency at Temple University. Following his time in Philadelphia, he relocated to the Bay Area to obtain his abdominal organ transplant fellowship training at UCSF.

He is returning to San Francisco from the University of Texas Health Science Center at San Antonio, where he is currently the Assistant Surgical Director of the Living Donor Liver Transplant program, which performs over fifty adult and pediatric living donor liver transplants annually. He also has a special interest in robotic hepatobiliary surgery and is excited to help advance our liver transplant program towards performing living donor hepatectomies with a purely robotic approach, with the goal of shortening recovery time and decreasing incision-related morbidity for donors, as well as increasing community interest in live liver donation.

Dr. Yamaguchi's research interests include the use of machine learning and artificial intelligence by clinicians in the field of solid organ transplantation, the treatment of hepatocellular carcinoma, and the optimization of the pre-liver transplant patient. He has a personal commitment to surgical education and has been heavily involved with residents in the development of training curricula that make use of low- and high-fidelity models to simulate procedures in HPB and transplant surgery, including models that make use of cryobanked cadaveric organs and tissue.

Data provided by UCSF Profiles, powered by CTSI
  1. Chen AK, Lunow-Luke T, Yamaguchi S, Praglin C, Agudelo E, Mehta N, Dirks R, Braun HJ, Gardner JM, Roberts JP, Syed SM, Roll GR. Nodular Regenerative Hyperplasia After Liver Transplant; It's All in the Presentation. Front Surg. 2022; 9:876818. View in PubMed
  2. Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation. Front Surg. 2021; 8:808733. View in PubMed
  3. Hirashima T, Arai T, Kitajima H, Tamura Y, Yamada T, Hashimoto S, Morishita H, Minamoto S, Kawashima K, Kashiwa Y, Kameda M, Takeshita T, Suzuki H, Matsuoka H, Yamaguchi S, Tanaka T, Nagai T. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study. J Infect Chemother. 2021 Jan; 27(1):76-82. View in PubMed
  4. Thiessen C, Wisel SA, Yamaguchi S, Dietch ZC, Feng S, Freise CE. Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis. Transplant Proc. 2020 Nov; 52(9):2596-2600. View in PubMed
  5. Nunn A, Prakash P, Inaba K, Escalante A, Maher Z, Yamaguchi S, Kim DY, Maciel J, Chiu WC, Drumheller B, Hazelton JP, Mukherjee K, Luo-Owen X, Nygaard RM, Marek AP, Morse BC, Fitzgerald CA, Bosarge PL, Jawa RS, Rowell SE, Magnotti LJ, Ong AW, Brahmbhatt TS, Grossman MD, Seamon MJ. Occupational exposure during emergency department thoracotomy: A prospective, multi-institution study. J Trauma Acute Care Surg. 2018 07; 85(1):78-84. View in PubMed
  6. View All Publications


Site Directory